Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis
- PMID: 17724144
- DOI: 10.1182/blood-2007-06-096503
Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis
Abstract
Inadequate hepcidin synthesis leads to iron overload in HFE-related hemochromatosis. We explored the regulation of hepcidin by iron in 88 hemochromatosis patients (61 C282Y/C282Y, 27 C282Y/H63D) and 23 healthy controls by analyzing urinary hepcidin before and 24 hours after a 65-mg oral iron dose. Thirty-four patients were studied at diagnosis and had iron overload, and 54 patients were iron depleted. At diagnosis, hepcidin values in C282Y homozygotes were similar to controls, whereas values in C282Y/H63D heterozygotes were higher (P = .02). However, the hepcidin/ferritin ratio was decreased in both homozygotes (P < .001) and heterozygotes (P = .017), confirming the inadequate hepcidin production for the iron load with both genotypes. In iron-depleted patients of both genotypes studied at a time remote from phlebotomy, basal hepcidin was still lower than in controls (P < .001 for C282Y/C282Y and P = .002 for heterozygotes). After an iron challenge, mean urinary hepcidin excretion increased in controls (P = .001) but not patients, irrespective of genotype and iron status. Significant hepcidin increase ( > or = 10 ng/mg creatinine) was observed in 74% of controls, 15% of homozygotes, and 32% of heterozygotes. The hepcidin response to oral iron is blunted in HFE-related hemochromatosis and not improved after iron depletion. The findings support the involvement of HFE in iron sensing and subsequent regulation of hepcidin.
Similar articles
-
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis.Haematologica. 2011 Apr;96(4):500-6. doi: 10.3324/haematol.2010.033449. Epub 2010 Dec 20. Haematologica. 2011. PMID: 21173098 Free PMC article.
-
Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.Eur J Gastroenterol Hepatol. 2011 Aug;23(8):721-4. doi: 10.1097/MEG.0b013e3283484716. Eur J Gastroenterol Hepatol. 2011. PMID: 21654321
-
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis.Blood Cells Mol Dis. 2008 May-Jun;40(3):347-52. doi: 10.1016/j.bcmd.2007.10.001. Epub 2007 Dec 27. Blood Cells Mol Dis. 2008. PMID: 18164223
-
Factors influencing disease phenotype and penetrance in HFE haemochromatosis.Hum Genet. 2010 Sep;128(3):233-48. doi: 10.1007/s00439-010-0852-1. Epub 2010 Jul 6. Hum Genet. 2010. PMID: 20607553 Review.
-
Contribution of different HFE genotypes to iron overload disease: a pooled analysis.Genet Med. 2000 Sep-Oct;2(5):271-7. doi: 10.1097/00125817-200009000-00001. Genet Med. 2000. PMID: 11399207 Review.
Cited by
-
Iron Protein Succinylate in the Management of Iron Deficiency Anemia: A Comparative Study with Ferrous Sulphate at Low and High Therapeutic Doses.Nutrients. 2021 Mar 17;13(3):968. doi: 10.3390/nu13030968. Nutrients. 2021. PMID: 33802720 Free PMC article.
-
Mechanisms of mammalian iron homeostasis.Biochemistry. 2012 Jul 24;51(29):5705-24. doi: 10.1021/bi300752r. Epub 2012 Jul 9. Biochemistry. 2012. PMID: 22703180 Free PMC article. Review.
-
Hepcidin in beta-thalassemia.Ann N Y Acad Sci. 2010 Aug;1202:31-5. doi: 10.1111/j.1749-6632.2010.05585.x. Ann N Y Acad Sci. 2010. PMID: 20712769 Free PMC article.
-
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis.Haematologica. 2011 Apr;96(4):500-6. doi: 10.3324/haematol.2010.033449. Epub 2010 Dec 20. Haematologica. 2011. PMID: 21173098 Free PMC article.
-
NTBI levels in C282Y homozygotes after therapeutic phlebotomy.EJHaem. 2022 Jul 27;3(3):644-652. doi: 10.1002/jha2.507. eCollection 2022 Aug. EJHaem. 2022. PMID: 36051052 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical